Medical ProductsCompany
Depomed - Diabetes Royalty Rights Ownership
Who owns Depomed - Diabetes Royalty Rights?
Depomed - Diabetes Royalty Rights is owned by PDL BioPharma. It was acquired on November 4, 2015.
Depomed - Diabetes Royalty Rights Business Overview
Where is Depomed - Diabetes Royalty Rights headquartered?
Depomed - Diabetes Royalty Rights is headquartered in United States.
What sector is Depomed - Diabetes Royalty Rights in?
Depomed - Diabetes Royalty Rights is a medical products company.
Medical Products M&A Summary in 2015
Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2015. The largest medical products acquisition in 2015 was Sirona Dental Systems - which was acquired by Dentsply Sirona for $5.6B.
Join Mergr to view all 267 acquisitions of medical products companies in 2015, including 25 acquisitions by private equity firms, and 242 by strategics.